Sedana Medical AB (SEDANA)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 9.860 |
|---|---|
| 52-week range | 7.900 – 13.920 |
| Return, 1 month / 3 months | −3.7% / +12.0% |
| Return, 1 year / 3 years | −7.9% / −46.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 50 |
| Volatility (1 year) | 54.6% |
| Worst drawdown (1 year) | -31.6% |
| Average daily value traded | 1.74M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sedana Medical is a Swedish medical device and pharmaceutical company focused on inhaled sedation in intensive care. Its main offering is a delivery system that allows anaesthetic gas to be administered to patients on mechanical ventilation, together with the related anaesthetic agent. The company serves hospitals and intensive care units, mainly in Europe, and works with clinicians who sedate critically ill patients. Its activities combine device development with regulatory work and commercial partnerships for its sedation products.
The shares are listed on the Nasdaq Stockholm in Sweden under the code SEDANA, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sedana Medical AB (SEDANA) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 9.860 on 27 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 296 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.9% and over the last three months it rose 12.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.0% | ||
| From 52-week high | -27.6% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.0% | ||
| 6-month return | 3.0% | ||
| 12-month return, skipping the last month | -4.3% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 54.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.6% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.74M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | −3.7% |
| 3 months | +12.0% |
| 6 months | +3.0% |
| 1 year | −7.9% |
| 3 years | −46.4% |
| 5 years | −87.8% |
Signals
| 50-day / 200-day average | 10.380 / 9.664 |
|---|---|
| Golden / death cross (60 days) | Golden, 43 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.451 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.